Fred Cohen

Fred Cohen

Directeur/Membre du Conseil chez INTELLIA THERAPEUTICS, INC.

Fortune : 7 M $ au 31/05/2026

69 ans
Health Technology
Finance
Commercial Services

Profil

Fred Ehrenkranz Cohen founded TPG Biotechnology Partners LP in 2001, where he worked as Managing Director & Partner from 2001 to 2016, Cell Design Labs, Inc. in 2016, where he worked as Chairman from 2016 to 2017, Vida Ventures LLC in 2017, where he worked as Senior Managing Director, and various other companies.
Dr. Cohen also currently works at Quintiles Transnational Corp., as Director, Acumen, Inc., as Director, Novotech (Australia) Pty Ltd., as Director, and various other companies.
Dr. Cohen also formerly worked at BioCryst Pharmaceuticals, Inc., as Independent Director from 2013 to 2019, Progyny, Inc., as Independent Director from 2015 to 2025, Kosan Biosciences, Inc., as Senior Director-Business Development, and various other companies.
Dr. Cohen received his doctorate degree in 1984 from Stanford University, doctorate degree in 1980 from the University of Oxford, and undergraduate degree in 1978 from Yale University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
12/06/2026 155 265 ( 0,3 % ) 4 M $ 31/05/2026
09/06/2026 216 653 ( 0,16 % ) 3 M $ 31/05/2026
05/06/2025 15 000 ( 0,03 % ) 421 950 $ 31/05/2026
27/05/2026 21 727 ( 0,04 % ) 185 114 $ 31/05/2026

Postes actifs de Fred Cohen

SociétésPosteDébut
INTELLIA THERAPEUTICS, INC. Directeur/Membre du Conseil 24/01/2019
KYVERNA THERAPEUTICS, INC. Directeur/Membre du Conseil 01/01/2018
CAREDX, INC. Directeur/Membre du Conseil 01/01/2014
Directeur/Membre du Conseil -
Fondateur 01/01/2017
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil 02/12/2020
Novotech Aus Holdco Pty Ltd.
Directeur/Membre du Conseil 01/02/2018
░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
░░░░░░░░ ░░░░░░░░ ░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -

Anciens postes connus de Fred Cohen

SociétésPosteFin
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░ ░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Fred Cohen

Formation de Fred Cohen

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

58

Relations au 1er degré

58

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées58

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Services

Health Technology

Health Services

Health Technology

Health Technology

Producer Manufacturing

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Finance

Consumer Services

Consumer Services

Electronic Technology

Health Technology

Consumer Services

Consumer Services

Producer Manufacturing

Commercial Services

Miscellaneous

Commercial Services

Commercial Services

Health Technology

Finance

Finance

Health Technology

Matrix Pharmaceuticals, Inc.

Health Technology

National Academy of Medicine

Finance

Health Technology

Miscellaneous

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Finance

Finance

Health Technology

Acrostar Pharmaservices Corp.

Commercial Services

Novotech Aus Holdco Pty Ltd.

Health Technology

Health Technology

Finance

Health Technology

Finance

Health Technology

  1. Bourse
  2. Insiders
  3. Fred Cohen
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT
🔇